The Defense Health Agency awarded a significant Other Transaction Indefinite Delivery Vehicle (IDV) agreement to the Medical Technology Enterprise Consortium (MTEC), a nonprofit medical technology accelerator, with a total value of $3,466,511.50. Under this IDV, the Defense Health Agency can efficiently issue task orders to MTEC for various medical technology development efforts.
Key projects under this IDV include the development of technologies to enable nighttime austere resuscitative and surgical care using night vision, which aligns with the military's priorities in operational medicine and medical modernization. MTEC, leveraging its broad consortium of industry, academic, and government partners, has delivered over $500 million in prototypes, research and development, data analytics, and medical countermeasures to support federal agencies' medical technology priorities. The task orders awarded under this IDV, which do not have set-aside designations, cover a wide range of medical research and development areas such as combat wound treatment, brain health technologies, COVID-19 diagnostics and therapeutics, and the development of oxygen carriers for hemorrhagic shock resuscitation.
Generated 1/6/25, 12:25 PM